| 注册
首页|期刊导航|实用肝脏病杂志|腹腔镜肝切除联合微波消融治疗肝细胞癌患者疗效及安全性评价

腹腔镜肝切除联合微波消融治疗肝细胞癌患者疗效及安全性评价

吕永祥 郑伟

实用肝脏病杂志2016,Vol.19Issue(6):692-695,4.
实用肝脏病杂志2016,Vol.19Issue(6):692-695,4.DOI:10.3969/j.issn.1672-5069.2016.06.013

腹腔镜肝切除联合微波消融治疗肝细胞癌患者疗效及安全性评价

Clinical efficacy and safety of microwave ablation combined with laparoscopic liver resection in treatment of patients with hepatocellular carcinoma

吕永祥 1郑伟2

作者信息

  • 1. 714000 陕西省渭南市第一医院普外科
  • 2. 陕西省人民医院肝胆外科
  • 折叠

摘要

Abstract

Objective To explore the clinical efficacy and safety of microwave ablation combined with laparoscopic liver resection in treatment of patients with hepatocellular carcinoma(HCC)with underlying liver cirrhosis. Methods 70 patients with HCC and underlying liver cirrhosis were accepted in our hospital between March 2009 and March 2015. 38 patients in observation group underwent microwave ablation combined with laparoscopic liver resection and 32 patients in control group underwent laparoscopic liver resection. The perioperative parameters,liver function indexes before and after treatment,complete resection rate,recurrence rate,and complications in the two groups were observed and compared. Results The operation time in observation group was (162.3±32.4)min,obviously longer than in control group [(131.0±27.9) min,P<0.05],and the blood loss,drainage tube removal time and hospital stays in observation group were[(132.5±25.6)mL,(5.2±1.3)d and(7.3±1.8)d],less or shorter than in control group[(368.4±67.1) mL,(7.0±1.6) d and (10.4±2.0) d,P<0.05];serum bilirubin and alanine transaminase levels 7 days after operation in observation group were[(19.7±5.2)μmol/L and(86.7±31.4)IU/L],obviously lower than in control group[(24.1±5.8)μmol/L and (132.6±27.5)IU/L,P<0.05];serum albumin in the two groups were[(43.3±10.8)g/L and (32.4±10.1)g/L,P<0.05],while the prothrombin time international normalized ratio in the two groups were not significantly different(P>0.05);The complete resection rate in the observation group was 94.74%,obviously higher than 78.13% (P<0.05)in the control group;the recurrence rate in the observation group was 7.89%,much lower than in the control group (28.13%,P<0.05). Conclusion Microwave ablation combined with laparoscopic liver resection has a good efficacy and safety in treatment of patients with HCC and liver cirrhosis.

关键词

肝细胞癌/肝硬化/微波消融/腹腔镜肝切除/疗效

Key words

Hepatoma/Liver cirrhosis/Microwave ablation/Laparoscopic liver resection/Efficacy

引用本文复制引用

吕永祥,郑伟..腹腔镜肝切除联合微波消融治疗肝细胞癌患者疗效及安全性评价[J].实用肝脏病杂志,2016,19(6):692-695,4.

实用肝脏病杂志

OACSTPCD

1672-5069

访问量0
|
下载量0
段落导航相关论文